Revenue
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.9M | $3.5M | $0 | — | — |
| Gross profit | $592,905 | $811,236 | — | — | — |
| Gross margin | 20.40% | 22.98% | — | — | — |
| Research & development | $318,446 | $161,155 | — | — | — |
| Operating expenses | $18.9M | $12.5M | $1.8M | — | — |
| Operating income | −$18.3M | −$11.7M | −$1.8M | −$35,388 | −$3,308 |
| Operating margin | −631.01% | −331.20% | — | — | — |
| EBITDA | −$9.0M | −$2.1M | $944,591 | — | — |
| EBITDA margin | −310.75% | −58.23% | — | — | — |
| Net income | −$27.1M | −$2.4M | $403,780 | −$35,388 | −$3,308 |
| Net profit margin | −931.19% | −68.29% | — | — | — |
| Basic EPSper basic share | -$0.92 | -$4.79 | $0.05 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | -$0.80 | -$4.79 | $0.05 | -$0.01 | $0.00 |
Reported shareholders
| Holder | % owned |
|---|---|
Hwang Kuk Hyoun | ≈69.24%24.32M shares |
BCM Europe AG | ≈21.45%7.53M shares |
Bellevue Capital Management LLC | ≈8.90%3.12M shares |
Bellevue Global Life Science Investors LLC | ≈5.82%2.04M shares |
VANGUARD FIDUCIARY TRUST CO | 0.42%148.27K shares |
CITADEL ADVISORS LLC | 0.36%127.81K shares |
JANE STREET GROUP, LLC | 0.36%127.2K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.29%100.46K shares |
TWO SIGMA SECURITIES, LLC | 0.13%46.54K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.11%37.37K shares |
XTX Topco Ltd | 0.09%32.38K shares |
Kim Yeiseok | ≈0.07%24.7K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05%18.28K shares |
NORTHERN TRUST CORP | 0.03%10.91K shares |
Mint Tower Capital Management B.V. | 0.02%7.5K shares |
Tower Research Capital LLC (TRC) | 0.02%6.59K shares |
UBS Group AG | <0.01%580 shares |
SBI Securities Co., Ltd. | <0.01%137 shares |
Percentages use 35.12M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.